Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
- 专利权人:
- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- 发明人:
- 申请号：
- IL23948515
- 公开号：
- IL239485D0
- 申请日:
- 2015.06.17
- 申请国别(地区):
- IL
- 年份:
- 2015
- 代理人:
- 摘要：
- Cyclic-GMP-AMP (cGAMP), including 2′,3′-cGAMP, are used in pharmaceutical formulations (including vaccine adjuvants), drug screens, therapies and diagnostics.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY
- PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY
- PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY
- PHARMACEUTICAL TARGETING OF A MAMMALIAN CYCLIC DI-NUCLEOTIDE SIGNALING PATHWAY
- Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
